FDA Investigator Dustin R Abaonza

Dustin R Abaonza has conducted inspections on 85 sites in 7 countries as of 13 May 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
85
Last Inspection Date:
13 May 2024
Investigator Role:
FDA Investigator
Redica ID:
100001981
Countries of Inspections:
United States of America, United Kingdom of Great Britain and Northern Ireland, Japan, Bulgaria, Poland, Switzerland, Netherlands
FDA Investigators that have inspected at least one site in common with Dustin R Abaonza:
Adam S Freeman, Alla Dubrovsky, Althea A Williams, Andrace L Deyampert, Andrea A Branche, Andrea George, PhD, Andrew B Slarve, Angel K Sandhu, Anh M Lac, Arindam Dasgupta, PhD, Ashar P Parikh, Ashley A Mutawakkil, Barbara D Wright, Barbara J Wilcox, PhD, Calvin B Koerner, Capri R Woolridge, Cara L Alfaro, Carl Lee, Carole L Jones, CDR Rochelle B Young, RPh, MSA, CDR Sean T Creighton, Celeste K Wong, Chloe Anne Leong, Christine M Parmentier, Christopher R Czajka, Cynthia J Tsui, Damon A Growl, Daniel C Geffin, Daniel J Roberts, David G Eng, Diane Cvan Leeuwen, Don A Leeseberg, Dr. Mark J Seaton, PhD, Dr. Ralph M Bernstein, PhD, Dustin P Tran, Emily Shacter, Eric L Dong, BS, Francis J Eng, Gary L Zaharek, Gerald Feldman, Gerald M Feldman, PhD, Henry K Lau, Humberto Z Gomez, Huy T Pham, James A Lane, James R Evans, Janice R Small, Janice Wai, Jeanne Fringer, PhD, Jeffrey M Watson, Jeffrey W Shrifter, DPM, Jennifer L Degroot, Jennifer L Johnson, Joan T Briones, Joey V Quitania, Joseph Kutze, PhD, Joseph P Iser, MD, Joshua S Hunt, Julian C Hanson, Kellie L Thommes, RN, Keren Arkin, Kevin P Foley, Kim Lthomas Cruse, Kristi B Panzer, Kristin M Abaonza, Lakisha M Williams, Lance Mde Souza, MBA, Laurie P Norwood, Laverne Puckett, LCDR Jennifer H Rhyu, Linda Linh N Adams, Linh Tu, Lucila B Nwatu, Mabel M Lee, Maida Henesian (NMI), Marcia A Worley, Marie K Kinkade, Mariza M Jafary, Mark I Nakano, Mark W Babbitt, Marsha W Major, Mary Ewilkerson Brinsko, Mary R Hole, Megan E Kulas, Michael Shanks, MS, Michael T Cyrus, Michelle Rfrazier Jessen, PhD, Mihaly S Ligmond, Min Shanmabel Liu, Nathan R Moon, Nayan J Patel, Nicholas L Hunt, Nicholas Obiri, PhD, Nicole Yuen, Nympha V Florendo, Omotunde O Osunsanmi, Paul M Kawamoto, Peter E Baker, Peter Kessler, PhD, Phung, Randall P Zielinski, Raymond T Oji, Rebecca Rodriguez, Rebecca T Davis, Riley C Myers, PhD, Robert D Tollefsen, Rumany C Penn, PharmD, Sandra S Saniga, Scott N Lim, Serge L Beaucage, Shaquenta Y Perkins, Sharon K Thoma, PharmD, Sheilyn H Huang, Shelley H Beausoleil, Sherri J Jackson, Sherri N Rohlf, MD, Sidney B Priesmeyer, Siobhan A Gallagher, Stephanie A Slater, MS, Stephen K Doberstein, PhD, Steve P Yost, Stuart W Russell, Sunitha K Rajaram, PhD, Terrence Gee, Thea C Grome, Thomas N Adjabeng, Thomas R Beilke, Thuy T Nguyen, LCDR, Timothy C Grome, Truong Xuan Nguyen (Andy), Vien Q Le, Walden H Lee, William J Foust, William V Millar, Xiaojun Yan, Yi Wang, PhD, Yuanyuan Li, Yvette Mlacour Davis, Zerita White

Dustin R Abaonza's Documents

Publish Date Document Type Title
January, 2022 FDA 483 Nicola P. Klein, M.D. - Form 483, 2022-01-03
February, 2019 EIR Nektar Therapeutics - EIR, 2019-03-29
December, 2018 FDA 483 Rachael A. Callcut, M.D., M.S.P.H. - Form 483, 2018-12-13
April, 2022 FDA 483 Pharmacyclics LLC - Form 483, 2022-04-27
December, 2019 EIR Tricida Inc. - EIR, 2019-12-17
March, 2024 FDA 483 Genentech, Inc. - Form 483, 2024-03-12
October, 2018 FDA 483 Sherry L. Thomas, MD - Form 483, 2018-10-14
October, 2021 FDA 483 Adarsh Daswani, M.D. - Form 483, 2021-10-29
July, 2018 FDA 483 ASEGUA THERAPEUTICS LLC - Form 483, 2018-07-17
May, 2023 FDA 483 Fitbit LLC - Form 483, 2023-05-22
October, 2022 FDA 483 Shawn K. Hassler, M.D. - Form 483, 2022-10-27
January, 2022 EIR Nicola P. Klein, M.D. - EIR, 2022-01-03
August, 2019 FDA 483 Global Blood Therapeutics, Inc. - Form 483, 2019-08-12
June, 2019 FDA 483 Jazz Pharmaceuticals, Inc - Form 483, 2019-06-10
December, 2023 FDA 483 Bay Area Tumor Institute IRB - Form 483, 2023-12-14
October, 2019 FDA 483 Tusker Medical, Inc. - Form 483, 2019-10-08
April, 2024 FDA 483 Mark Savant, M.D. - Form 483, 2024-04-17
November, 2020 FDA 483 Michael L. Levin, M.D. - Form 483, 2020-11-25
August, 2022 FDA 483 Andrew Rezvani, M.D. - Form 483, 2022-08-19
May, 2018 FDA 483 J. Claude Hemphill III - Form 483, 2018-05-22
September, 2019 EIR Beigene USA, Inc. - EIR, 2019-10-02
April, 2017 FDA 483 Shunny Corporation dba Sampac Enterprise - Form 483, 2017-04-11
June, 2021 FDA 483 Adamas Pharmaceuticals, Inc. - Form 483, 2021-06-28
October, 2019 EIR Tusker Medical, Inc. - EIR, 2019-10-08
May, 2023 FDA 483 LimFlow, Inc. - Form 483, 2023-05-15
October, 2020 FDA 483 Bailey, Timothy S., MD - Form 483, 2020-10-13
March, 2021 FDA 483 Helen K. Chew, M.D. - Form 483, 2021-03-10
August, 2019 EIR Global Blood Therapeutics, Inc. - EIR, 2019-08-12

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more